effect of Midazolam prophylaxis on the seizures

Phase 1

Recruiting

• Conditions: Seizures.; Conversion disorder with seizures or convulsions; F44.5

• Registration Number: IRCT20180608040013N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Take tramadol tablets for the past 6 hours
Age over 16 years
No seizures before entering the study

Exclusion Criteria

Age over 70 years
History of epilepsy
Concomitant use of antidepressants
Concomitant use of other drugs with a dose of poisoning
History of underlying diseases
Trauma to the head

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Seizures. Timepoint: Up to 24 hours after hospitalization. Method of measurement: Based on the patient's records and interview with the patient in case of discharge before 24 hours.;Number of seizures. Timepoint: Up to 24 hours after hospitalization. Method of measurement: Based on the patient's records and interview with the patient in case of discharge before 24 hours.;The length of hospital stay. Timepoint: From hospitalization to discharge. Method of measurement: Based on patient records.;Need for mechanical ventilation. Timepoint: From hospitalization to discharge. Method of measurement: Based on patient records.